FEDERAL HEALTH POLICY STRATEGIES

Lobbying for PFIZER · Pharmaceutical Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New York · House · Senate · $60,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Implementation of the drug pricing provisions in the Inflation Reduction Act Drug pricing and prescription digital therapeutics

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.